Texas Medical Center (TMC)

United States of America (USA)

1 December 2019 - 30 November 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Texas Medical Center (TMC) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
10 2.01

Outputs by subject (Share)

Subject Count Share
Chemistry 8 1.87
1 0.05
5 1.30
Total Synthesis of the Monomeric Unit of Lomaiviticin A
Hydrogenation of Alkenes via Cooperative Hydrogen Atom Transfer
Streamlined Symmetrical Total Synthesis of Disorazole B1 and Design, Synthesis, and Biological Investigation of Disorazole Analogues
Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody–Drug Conjugates
Total Synthesis and Biological Evaluation of Tiancimycins A and B, Yangpumicin A, and Related Anthraquinone-Fused Enediyne Antitumor Antibiotics
1 0.03
1 0.50
Life Sciences 3 0.16

1 December 2019 - 30 November 2020

International vs. domestic collaboration by Share

  • 83.23% Domestic
  • 16.77% International

Note: Hover over the graph to view the percentage of collaboration.

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Return to institution outputs